With the rising incidence of cancer in India, AstraZeneca India’s breast cancer medicine trastuzumab deruxtecan (sold under the brand name Enhertu) emerged as the highest-selling new drug brand ...
Thus the value of the brand in the year prior to generic launch has an effect on the speed of price decay. In other words, the larger the value of the brand, the more generic companies there are ...
India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the top-seller, reflecting a rise in cancer cases. Enhertu, exempted from ...
In 2024, 94 cancer drug brands were launched, generating Rs 149.8 crore in turnover, while 505 vitamin-mineral-nutrient brands accounted for Rs 126 crore and 394 gastrointestinal brands ...
According to the Texas State Board of Pharmacy, state law does allow pharmacists to substitute a brand-name medication with a generic version as long as the patient doesn't refuse it or the doctor ...
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...
Several brand-name drugmakers believe they will withstand any drug pricing impacts from President Donald Trump’s tariffs — and manufacturers that contract ...
Taking control of your brand can mean the difference between an unfulfilling job and a rewarding career. But how can you persuade others to take the reinvented you seriously? The author presents a ...
In brand strategy, “brand personality” refers to a unique blend of human characteristics associated with a brand. These traits shape how people perceive and interact with the brand, whether seen as ...
Generic Eng Standalone December 2023 Net Sales at Rs 58.97 crore, down 5.09% Y-o-Y Mar 01 2024 01:54 PM Generic Eng Standalone September 2023 Net Sales at Rs 37.20 crore, down 30.48% Y-o-Y Dec 04 ...
Am J Health Syst Pharm. 2006;63(8):712-714. Drug information specialists are pharmacists whose primary responsibility is the provision of drug information. As with any specialty, formalized ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果